MINNEAPOLIS (CBP) – U.S. Customs and Border Protection (CBP) officers at Minneapolis-St. Paul Airport recently stopped a shipment filled with 2,536 pre-filled syringes of vaginal tightening gel. On November 20, CBP inspected a shipment arriving from Hong Kong manifested as “Vaginal Tightening Gel”. The shipment was found to contain commercial quantities of a gel inside injectables and required the user to wear chemical resistant gloves when handling. The packages containing the cosmetic gel were found in pink packaging appearing ready for resale.
In coordination with the U.S. Food and Drug Administration (FDA), the items were seized for violating the Federal Food, Drug, and Cosmetic Act. The shipment was destined for a residential address in Woodbury, MN. Had these items been sold, the total domestic value would have been over $19,000.
Medications purchased from online sources can be improperly produced without pharmacological specifications and safeguards that ensure the protection of human health. Medications manufactured in non-regulated foreign companies often contain dangerous contaminants or ineffective compounds, and though their packaging and labelling can be like genuine products, inconsistent ingredients and sub-par quality controls can endanger the consumer.
“This dangerous shipment is another example of someone using unregulated gels to prey on unknowing consumers with false promises,” said LaFonda D. Sutton-Burke, Director, Field Operations-Chicago Field Office. “Not knowing what you are inserting in your body can be deadly, and consumers believe they are getting a discount, when in fact they are purchasing an inferior product with unapproved ingredients.”